247 related articles for article (PubMed ID: 26648079)
21. Role of immunotherapy in the treatment of bladder and renal cell carcinoma.
Stone NN; Droller MJ
Semin Surg Oncol; 1991; 7(4):239-43. PubMed ID: 1925256
[TBL] [Abstract][Full Text] [Related]
22. Combination immunotherapy in genitourinary malignancies.
Hoffman-Censits J; Wilde L
Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
[TBL] [Abstract][Full Text] [Related]
23. Bibliography. Current world literature. Genitourinary system.
Curr Opin Oncol; 1999 May; 11(3):B116-30. PubMed ID: 10328603
[No Abstract] [Full Text] [Related]
24. Novel immunotherapy combinations for genitourinary cancers.
Al Harthy M; Redman J; Madan RA
Expert Opin Biol Ther; 2020 Mar; 20(3):253-262. PubMed ID: 31914333
[TBL] [Abstract][Full Text] [Related]
25. Genitourinary malignancy.
Giantonio B; Ozols RF; Hudes GR
Cancer Chemother Biol Response Modif; 1993; 14():498-529. PubMed ID: 8312117
[No Abstract] [Full Text] [Related]
26. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
[No Abstract] [Full Text] [Related]
27. Editorial: Emerging Immunotargets in Genitourinary Tumors.
Montironi R; Santoni M; Massari F; Lopez-Beltran A; Cheng L; Berardi R; Scarpelli M
Curr Drug Targets; 2016; 17(7):748-9. PubMed ID: 27086839
[No Abstract] [Full Text] [Related]
28. Genitourinary Cancer: Updates on Treatments and Their Impact on the Kidney.
Orozco Scott P; Deshpande P; Abramson M
Semin Nephrol; 2022 Nov; 42(6):151344. PubMed ID: 37172546
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer.
Stabile A; Muttin F; Zamboni S; Moschini M; Gandaglia G; Fossati N; Dell'Oglio P; Capitanio U; Cucchiara V; Mazzone E; Bravi CA; Mirone V; Montorsi F; Briganti A
Expert Rev Anticancer Ther; 2019 Sep; 19(9):739-755. PubMed ID: 31469021
[No Abstract] [Full Text] [Related]
30. Immunology of genitourinary tumors.
Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
[No Abstract] [Full Text] [Related]
31. Immunologic features of genitourinary cancer.
Javadpour N
Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
[No Abstract] [Full Text] [Related]
32. [Update uro-oncology: scientific meetings 2011].
Hegele A; Skrobek L; Schrader AJ
Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
[TBL] [Abstract][Full Text] [Related]
33. Sarcomatoid lesions of the urogenital tract.
Reuter VE
Semin Diagn Pathol; 1993 May; 10(2):188-201. PubMed ID: 8367626
[TBL] [Abstract][Full Text] [Related]
34. [The studies of natural killer cell activity in uro-genital cancer patients--investigation of natural killer cell activity from the standpoint of stage and antitumor therapy of genito-urinary tract carcinomas].
Fukasawa K
Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):239-45. PubMed ID: 3226000
[No Abstract] [Full Text] [Related]
35. Inside the 2015 ASCO Genitourinary Cancers Symposium.
Santoni M; Massari F; Iacovelli R; Ciccarese C; Verri E; Burattini L; Montironi R; Nolè F; Tortora G; Cascinu S
Future Oncol; 2015; 11(13):1859-62. PubMed ID: 26161923
[TBL] [Abstract][Full Text] [Related]
36. Genitourinary cancer in the elderly.
Mulholland SG; Stefanelli JL
Am J Kidney Dis; 1990 Oct; 16(4):324-8. PubMed ID: 2220779
[TBL] [Abstract][Full Text] [Related]
37. Biologic tools to personalize treatment in genitourinary cancers.
Bracarda S; Sisani M; Del Buono S; Ishiwa O; Montagnani F;
Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e42-8. PubMed ID: 21232974
[TBL] [Abstract][Full Text] [Related]
38. The Microbiome and Genitourinary Cancer: A Collaborative Review.
Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
[TBL] [Abstract][Full Text] [Related]
39. Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Small EJ; Halabi S; Kantoff P; D'Amico A; Stadler W; Kelley WK; Mohler J; Bajorin D; Vogelzang NJ
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3596s-600s. PubMed ID: 16740791
[TBL] [Abstract][Full Text] [Related]
40. [Combination radiotherapy-immunotherapy in genitourinary cancer].
Ollivier L; Guimas V; Rio E; Vaugier L; Masson I; Libois V; Labbé M; Fradin D; Potiron V; Supiot S
Cancer Radiother; 2021 Oct; 25(6-7):565-569. PubMed ID: 34391648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
